FDA grants Emergency Use Authorisation for Roche’s Coronavirus Test
Roche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read moreRoche’s coronavirus test has been granted Emergency Use Authorization by the U.S. Food and Drug Administration, the Swiss pharma giant
Read moreAscletis Pharma’s investigational Ganovo and Ritonavir combo-therapy shows promise in COVID-19 Clinical Trial. Chinese biotech Ascletis Pharma Inc. (HKEX code:
Read morePreclinical data on remdesivir indicates that the drug may have potential as a treatment against the new coronavirus COVID-19. Remdesivir
Read moreChina has approved Actemra to treat COVID-19 patients. Actemra, Roshe’s anti-inflammatory drug, has received the green light in China as
Read moreUS biotech company Gilead Sciences has announced the start of two clinical Phase 3 trials to evaluate the safety and
Read moreUS-based pharmaceutical company Inovio is one of a number of pharmaceutical companies and research facilities urgently trying to develop a
Read moreRoche has entered into a definitive merger agreement to buy US-based fibrosis specialist Promedior for up to $1.39 billion. The
Read moreOn October 24, 2019, NHS England reached a deal with the manufacturers Vertex Pharmaceuticals to make all three of their UK-licensed cystic
Read more